# Fady T. Botros

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/fady-t-botros/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,901 |
| Field | Diabetes Treatment and Management |
| h-index | 23 |
| i10-index | 30 |
| Last Known Institution | Eli Lilly (United States) |
| OpenAlex ID | https://openalex.org/A5051731762 |
| ORCID iD | 0000-0003-1980-4458 |
| Works | 64 |

## Researcher papers

- [Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial](https://scholariq.org/papers/dulaglutide-versus-insulin-glargine-in-patients-with-type-2-diabetes-and/)
- [Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial](https://scholariq.org/papers/dulaglutide-and-renal-outcomes-in-type-2-diabetes-an-exploratory-analysis-of-the/)
- [Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program](https://scholariq.org/papers/efficacy-and-safety-of-dulaglutide-in-the-treatment-of-type-2-diabetes-a/)
- [The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial](https://scholariq.org/papers/the-effect-of-dulaglutide-on-stroke-an-exploratory-analysis-of-the-rewind-trial/)
- [Tadalafil for the Treatment of Pulmonary Arterial Hypertension](https://scholariq.org/papers/tadalafil-for-the-treatment-of-pulmonary-arterial-hypertension/)
- [Collecting Duct Renin Is Upregulated in Both Kidneys of 2-Kidney, 1-Clip Goldblatt Hypertensive Rats](https://scholariq.org/papers/collecting-duct-renin-is-upregulated-in-both-kidneys-of-2-kidney-1-clip/)
- [Increase in heme oxygenase-1 levels ameliorates renovascular hypertension](https://scholariq.org/papers/increase-in-heme-oxygenase-1-levels-ameliorates-renovascular-hypertension/)
- [Monotherapy with the once‐weekly GLP‐1 analogue dulaglutide for 12 weeks in patients with Type 2 diabetes: dose‐dependent effects on glycaemic control in a randomized, double‐blind, placebo‐controlled study](https://scholariq.org/papers/monotherapy-with-the-once-weekly-glp-1-analogue-dulaglutide-for-12-weeks-in/)
- [Reciprocal changes in renal ACE/ANG II and ACE2/ANG 1–7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats](https://scholariq.org/papers/reciprocal-changes-in-renal-ace-ang-ii-and-ace2-ang-1-7-are-associated-with/)
- [Collecting duct renin: a major player in angiotensin II–dependent hypertension](https://scholariq.org/papers/collecting-duct-renin-a-major-player-in-angiotensin-ii-dependent-hypertension/)
- [Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate‐to‐severe chronic kidney disease (AWARD‐7)](https://scholariq.org/papers/body-weight-and-egfr-during-dulaglutide-treatment-in-type-2-diabetes-and/)
- [Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide](https://scholariq.org/papers/indicators-of-kidney-fibrosis-in-patients-with-type-2-diabetes-and-chronic/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Heme Oxygenase-1 and Carbon Monoxide](https://scholariq.org/topics/heme-oxygenase-1-and-carbon-monoxide/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)

## Researcher university

- [Eli Lilly (United States)](https://scholariq.org/institutions/eli-lilly-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.